Holen Sie sich die Stockscreener-App
365.08
8.33%
28.08
Finanzdaten der Bio-Rad Laboratories, Inc. Class B-Aktie (BIO.B)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
9.95%
651.00
|
592.10 | 693.20 | 653.00 | 651.60 |
| Cost Of Revenue |
7.96%
305.20
|
282.70 | 348.00 | 309.60 | 306.30 |
| Gross Profit |
11.76%
345.80
|
309.40 | 345.20 | 343.40 | 345.30 |
Selling, General, and Administrative
|
0.19%
212.00
|
212.40 | 221.00 | 206.80 | 207.70 |
| Interest Income/Expense |
1.63%
12.10
|
12.30 | 12.10 | 12.30 | 12.60 |
| Operating Income/Loss |
112.90%
72.60
|
34.10 | -118.90 | 65.30 | 77.10 |
| Income/Loss From Continuing Operations Before Tax |
178.59%
542.10
|
-689.80 | 929.20 | -431.10 | 414.00 |
| Income Tax Expense/Benefit |
204.92%
170.70
|
-162.70 | 209.20 | -89.20 | 96.20 |
| Net Income/Loss |
170.46%
371.40
|
-527.10 | 720.00 | -341.90 | 317.80 |
| Basic Average Shares |
0.79%
26.75
|
26.96 | - | 26.92 | 27.23 |
| Diluted Average Shares |
0.53%
26.81
|
26.96 | - | 26.92 | 27.23 |
| Basic Earnings Per Share |
171.05%
13.89
|
-19.55 | - | -12.70 | 11.67 |
| Diluted Earnings Per Share |
170.84%
13.85
|
-19.55 | - | -12.70 | 11.67 |
0.48%
3.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):